Topic resource collection
Approved comparison material connected to this topic.
7 resourcesRead both sides
5-Amino-1MQ targets NNMT and is a small molecule. GLP-1 or GIP/GLP-1 metabolic drugs work through incretin hormone receptors and have regulator-reviewed indications when used as approved products [18], [19]. That does not mean ap…
NNMT does not just affect NAD+ levels. It also influences gene expression patterns that control whether cells store or burn fat. When NNMT activity is high, fat cells become more efficient at lipogenesis, the process of creating …
For context, the dosing requirements of 5-amino-1mq differ significantly from traditional peptides. Where compounds like BPC-157 or TB-500 are dosed in micrograms, 5-amino-1mq is dosed in milligrams. This reflects its different c…
Understanding how 5-amino-1mq compares to other fat loss compounds helps researchers choose the most appropriate approach for their specific goals. Each option has distinct mechanisms, benefits, and limitations.
The following table compares how both naming conventions appear across different research contexts and what each context requires for experimental validity. In vitro enzyme assays (recombinant NNMT) 5-Amino-1MQ (systematic) 0.1–1…
Primary Mechanism NNMT inhibition → increased NAD+ → SIRT1 activation → fat oxidation GLP-1 receptor agonism → slowed gastric emptying + appetite suppression 5-amino-1mq targets cellular metabolism directly; GLP-1 works through s…
5-Amino-1MQ NNMT inhibition 7% reduction (11 days, mouse) High (IC50 1.2–3.8 μM) 28 days at 2–8°C Metabolic research, NAD+ pathway studies Nicotinamide Riboside (NR) NAD+ precursor supplementation Minimal direct effect on weight …